Nerve changes in children with leukemia during chemotherapy
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tracks how chemotherapy affects nerves in children aged 8 to 17 with acute lymphoblastic leukemia. It aims to understand who may experience nerve problems, helping doctors better manage symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with acute lymphoblastic leukemia
- Aged 8 to 17 years
- Will receive vincristine chemotherapy as part of the CCCG-ALL-2020 treatment plan
- Able to understand and describe how you feel physically and emotionally
- Child and parent must agree to participate and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a gentle electrical stimulation applied to specific body points (acupoints) can help reduce nerve pain and tingling caused by chemotherapy in children with leukemia. It aims to see if the treatment is safe and helpful.
This study tests whether gentle electrical stimulation on the skin and ear acupressure can help reduce chemotherapy-related nerve pain and numbness in children with leukemia. It might help improve comfort and daily function during treatment.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This trial tests a treatment plan for children with newly diagnosed acute lymphoblastic leukemia (ALL) that is considered standard-risk. It aims to see if the treatment is effective and safe.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This study looks at genetic (DNA) differences to understand acute lymphoblastic leukemia (ALL) in Indian children and how treatments may fit better. You may be able to join if your child is newly diagnosed, meets the study’s treatment plan rules, and provides consent.
Hear when a new Acute Lymphoblastic Leukemia ALL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.